| 52.88 Data as of May 10 | +0.09 / +0.17%Today’s Change | 24.12 Today|||52-Week Range 56.35 | +43.99% Year-to-Date |
| Cramer: Biotech Makes a Comeback May 10 / TheStreet.com | 4 Stocks Pushing The Drugs Industry Downward May 07 / TheStreet.com |
| Biotech Makes a Comeback May 10 / TheStreet.com | Gilead Misses on Earnings, Sales in 1Q - Analyst Blog May 03 / Zacks.com |
| Off the Charts May 09 / TheStreet.com | Double Setback for Gilead - Analyst Blog Apr 30 / Zacks.com |
| Biotech Is Where the Bucks Are May 09 / TheStreet.com | Apple And Other Assorted Scenarios Apr 23 / StockTwits |
| Gilead Sciences Inc Stock Buy Recommendation Reiterated (GILD) May 08 / TheStreet.com | Momentum Wrap – Biotech And Retail Stocks Lead The Market Higher Apr 11 / StockTwits |
| Previous close | 52.79 |
| Today’s open | 52.77 |
| Day’s range | 52.19 - 53.15 |
| Volume | 12,753,060 |
| Average volume (3 months) | 11,306,899 |
| Market cap | $80.7B |
| Dividend yield | -- |
| Earnings growth (last year) | -7.61% |
| Earnings growth (this year) | +1.39% |
| Earnings growth (next 5 years) | +27.25% |
| Revenue growth (last year) | +13.58% |
| P/E ratio | 29.5 |
| Price/Sales | 5.79 |
| Price/Book | 8.63 |
| Today’s change | Today’s % change | |
|---|---|---|
| AMGNAmgen Inc | +2.16 | +2.07% |
| BIIBBiogen Idec Inc | +3.94 | +1.88% |
| BAXBaxter International... | -0.23 | -0.32% |
| LIFELife Technologies Co... | -0.01 | -0.01% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $9.6B |
| Annual profit (last year) | $2.6B |
| Net profit margin | 26.96% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer John C. Martin, PhD, MBA |
President & Chief Operating Officer John F. Milligan, PhD |
Corporate headquarters Foster City, California |
